JP Morgan Maintains Neutral on BJ's Wholesale Club Hldgs, Raises Price Target to $113
JP Morgan analyst Christopher Horvers maintains BJ's Wholesale Club Hldgs (NYSE:BJ) with a Neutral and raises the price target from $100 to $113.
Follow the latest BJs Wholesale Club Holdings, Inc. (BJ) news and market headlines alongside the live BJ price. Stay informed on what's moving BJ.
JP Morgan analyst Christopher Horvers maintains BJ's Wholesale Club Hldgs (NYSE:BJ) with a Neutral and raises the price target from $100 to $113.
Wells Fargo analyst Edward Kelly maintains BJ's Wholesale Club Hldgs (NYSE:BJ) with a Overweight and raises the price target from $110 to $120.
BJ's Wholesale Club is highlighted as a compelling growth stock investment opportunity, earning a Growth Score of A and Zacks Rank #2 (Buy). The company demonstrates strong fundamentals including projected EPS growth of 6.9% (above the 3.1% industry average), year-over-year cash flow growth of 8.3% (versus 3.1% industry average), and positive earnings estimate revisions, positioning it well for potential outperformance.
In a comparison of two Consumer Products - Staples sector stocks, BJ's Wholesale Club emerges as the better value opportunity. BJ holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a forward P/E of 23.54 and PEG ratio of 3.25. Colgate-Palmolive has a Zacks Rank #3 (Hold) with a Value grade of D, showing a forward P/E of 25.02 and PEG ratio of 4.44. BJ's stronger earnings estimate revisions and more attractive valuation metrics make it the superior choice for value investors.
The Consumer Products-Staples industry is navigating a challenging environment marked by elevated raw material, labor, and transportation costs, alongside heightened consumer price sensitivity and spending volatility. Companies are pursuing cost optimization, digital investments, and portfolio optimization strategies. The industry carries a Zacks Industry Rank #194 (bottom 21%), reflecting negative earnings outliers, though it has outperformed the S&P 500 over the past year with a 10.4% gain.
Casey's General Stores (CASY) reported Q1 inside sales growth of 5.6% to $1.78 billion with same-store sales up 3.2%. Prepared food sales surged 7.4% driven by whole pizza offerings, while grocery sales benefited from energy drinks and nicotine alternatives growing 47%. The company's inside margin improved to 42.2%, exceeding its fiscal 2027 target, and management reiterated its full-year outlook for 2-5% inside same-store sales growth.
Sally Beauty Holdings reported Q4 fiscal 2026 results beating consensus estimates with adjusted EPS of 62 cents (up 12.7%) and sales of $952.5 million (up 0.6%). E-commerce sales grew 8% to $113 million, and adjusted operating margin expanded 60 basis points to 10%. The company projects fiscal 2027 sales of $3.77-$3.81 billion with adjusted EPS of $2.20-$2.30, while planning approximately 100 additional Sally Ignited store locations.
Estee Lauder introduced Mastering Skin Longevity, a scientific innovation platform built on over 20 years of research to accelerate product development in anti-aging and skin health. The platform unites five brands (Estee Lauder, La Mer, Clinique, Lab Series, and The Ordinary) and focuses on Master Regulators of Skin Longevity. The company expects fiscal 2027 organic sales growth of 4-5.5% with adjusted operating margins of 12.9-13.7%, supported by recent 4% organic skin care sales growth and 9% growth in Mainland China.
Grocery Outlet reported Q3 fiscal 2026 results beating earnings and sales estimates, with adjusted EPS of 16 cents and net sales of $1.18 billion. Comparable-store sales grew 0.5% driven by 2.4% transaction growth, though gross margin contracted 40 basis points due to promotional spending and higher transportation costs. The company raised its fiscal 2026 comparable-store sales outlook to 0.2%-0.4% growth while narrowing EBITDA guidance, reflecting improved operating momentum despite continued margin pressures.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to BJ, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.